Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 324,800 shares, a decline of 22.0% from the April 30th total of 416,400 shares. Based on an average daily volume of 671,600 shares, the […]